Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  498 results for ""Receptors, Vascular Endothelial Growth Factor""

Your Filters

Subject : ranibizumab
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

BNT162b2 vaccine booster dose did not influence the activity of the exudative form of age-related macular degeneration during anti-vascular endothelial growth factor therapy.

  • Authors : Płatkowska-Adamska B; Medical and Health Sciences, Collegium Medicum, Jan Kochanowski University, Kielce, Poland - .; Department of Ophthalmology, John Boni Fratres Lodziensis, Łódź, Poland - .

Subjects: BNT162 Vaccine*/BNT162 Vaccine*/BNT162 Vaccine*/administration & dosage ; BNT162 Vaccine*/BNT162 Vaccine*/BNT162 Vaccine*/adverse effects ; Recombinant Fusion Proteins*/Recombinant Fusion Proteins*/Recombinant Fusion Proteins*/administration & dosage

  • Source: Minerva medica [Minerva Med] 2024 Dec; Vol. 115 (6), pp. 643-650. Date of Electronic Publication: 2024 Oct 11.Publisher: Edizioni Minerva Medica Country of Publication: Italy NLM ID: 0400732 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Branch retinal vein occlusion treated with anti-VEGF: to switch or not to switch?

  • Authors : Shor R; Department of Ophthalmology, Tel Aviv Sourasky Medical Center, affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.; Segal O

Subjects: Retinal Vein Occlusion*/Retinal Vein Occlusion*/Retinal Vein Occlusion*/drug therapy ; Retinal Vein Occlusion*/Retinal Vein Occlusion*/Retinal Vein Occlusion*/physiopathology ; Retinal Vein Occlusion*/Retinal Vein Occlusion*/Retinal Vein Occlusion*/diagnosis

  • Source: Canadian journal of ophthalmology. Journal canadien d'ophtalmologie [Can J Ophthalmol] 2024 Dec; Vol. 59 (6), pp. e824-e829. Date of Electronic Publication: 2024 Feb 22.Publisher: Elsevier Country of Publication: England NLM ID: 0045312 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1715-3360

Record details

Read More Add to Saved list
×
Academic Journal

Systemic effects of anti-VEGF intravitreal injection in patients with age-related macular degeneration: A multi-institutional real-world study.

  • Authors : Lin TY; Department of Education, Chang Gung Memorial Hospital, Linkou Medical Center, Taoyuan, Taiwan.; College of Medicine, Chang Gung University, Taoyuan, Taiwan.

Subjects: Intravitreal Injections* ; Angiogenesis Inhibitors*/Angiogenesis Inhibitors*/Angiogenesis Inhibitors*/administration & dosage ; Angiogenesis Inhibitors*/Angiogenesis Inhibitors*/Angiogenesis Inhibitors*/adverse effects

  • Source: Indian journal of ophthalmology [Indian J Ophthalmol] 2024 Nov 01; Vol. 72 (Suppl 5), pp. S809-S815. Date of Electronic Publication: 2024 Aug 14.Publisher: Medknow Publications Country of Publication: India NLM ID: 0405376 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read Online Read More Add to Saved list
×
Academic Journal

The impact of Vitreo-Macular interface abnormalities on the response to Anti-VEGF therapy for centre involving diabetic macular oedema.

  • Authors : Maguire M; Department Academic Ophthalmology, Guy's and saint Thomas' NHS Trust, London, SE1 7EH, UK. .; Laidlaw D

Subjects: Macular Edema*/Macular Edema*/Macular Edema*/drug therapy ; Macular Edema*/Macular Edema*/Macular Edema*/diagnosis ; Macular Edema*/Macular Edema*/Macular Edema*/etiology

  • Source: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie [Graefes Arch Clin Exp Ophthalmol] 2024 Nov; Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 8205248 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

A comparation of three different anti-VEGF drugs in development of persistent avascular retina in premature children.

  • Authors : Ünal AC; Department of Ophthalmology, University of Health Sciences, Antalya Education and Research Hospital, Antalya, 07050, Turkey. .; Akıdan M

Subjects: Retinopathy of Prematurity*/Retinopathy of Prematurity*/Retinopathy of Prematurity*/drug therapy ; Vascular Endothelial Growth Factor A*/Vascular Endothelial Growth Factor A*/Vascular Endothelial Growth Factor A*/antagonists & inhibitors ; Ranibizumab*/Ranibizumab*/Ranibizumab*/therapeutic use

  • Source: Scientific reports [Sci Rep] 2024 Dec 28; Vol. 14 (1), pp. 31097. Date of Electronic Publication: 2024 Dec 28.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Real-world visual acuity outcomes for patients with naïve neovascular age-related macular degeneration treated with aflibercept, ranibizumab, or bevacizumab in the Republic of Korea.

  • Authors : Lee YJ; Department of Ophthalmology and Visual Science, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.; Department of Ophthalmology and Visual Science, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.

Subjects: Receptors, Vascular Endothelial Growth Factor*/Receptors, Vascular Endothelial Growth Factor*/Receptors, Vascular Endothelial Growth Factor*/therapeutic use ; Receptors, Vascular Endothelial Growth Factor*/Receptors, Vascular Endothelial Growth Factor*/Receptors, Vascular Endothelial Growth Factor*/administration & dosage ; Recombinant Fusion Proteins*/Recombinant Fusion Proteins*/Recombinant Fusion Proteins*/therapeutic use

  • Source: PloS one [PLoS One] 2024 Oct 03; Vol. 19 (10), pp. e0310381. Date of Electronic Publication: 2024 Oct 03 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Three-Year Outcomes of VEGF Inhibitors in Naive Branch Retinal Vein Occlusion: Fight Retinal Blindness!

Subjects: Retinal Vein Occlusion*/Retinal Vein Occlusion*/Retinal Vein Occlusion*/drug therapy ; Retinal Vein Occlusion*/Retinal Vein Occlusion*/Retinal Vein Occlusion*/diagnosis ; Retinal Vein Occlusion*/Retinal Vein Occlusion*/Retinal Vein Occlusion*/complications

  • Source: Ophthalmology. Retina [Ophthalmol Retina] 2024 Oct; Vol. 8 (10), pp. 962-970. Date of Electronic Publication: 2024 Apr 18.Publisher: Published by Elsevier Inc. on behalf of American Academy of Ophthalmology Country of Publication: United States NLM ID: 101695048 Publication Model:

Record details

Read More Add to Saved list
×
Academic Journal

Vitrectomy as an Adjunct to Treat-and-Extend Anti-VEGF Injections for Diabetic Macular Edema: The Vitrectomy in Diabetic Macular Oedema (VIDEO) Randomized Clinical Trial.

  • Authors : Maguire MJ; Department of Academic Ophthalmology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.; Laidlaw A

Subjects: Vitrectomy* ; Diabetic Retinopathy*/Diabetic Retinopathy*/Diabetic Retinopathy*/drug therapy ; Diabetic Retinopathy*/Diabetic Retinopathy*/Diabetic Retinopathy*/surgery

  • Source: JAMA ophthalmology [JAMA Ophthalmol] 2024 Sep 01; Vol. 142 (9), pp. 837-844.Publisher: American Medical Association Country of Publication: United States NLM ID: 101589539 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

One-Year Functional and Morphological Prognosis After Intravitreal Injection Treatments According to Different Morphological Patterns of Diabetic Macular Edema in Real-Life: MARMASIA Study Group Report No.13.

  • Authors : Limon DU; Ümraniye Education and Research Hospital, Department of Ophthalmology, University of Health Sciences, Istanbul, Turkey.; Kaplan FB

Subjects: Intravitreal Injections* ; Macular Edema*/Macular Edema*/Macular Edema*/drug therapy ; Macular Edema*/Macular Edema*/Macular Edema*/diagnosis

  • Source: Seminars in ophthalmology [Semin Ophthalmol] 2024 Aug; Vol. 39 (6), pp. 460-467. Date of Electronic Publication: 2024 Mar 05.Publisher: Informa Healthcare Country of Publication: England NLM ID: 8610759 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Efficacy and Safety of Aflibercept and Ranibizumab in the Treatment of Retinopathy of Prematurity.

  • Authors : Yang T; Department of Neonatal Pediatrics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.; Zhang J

Subjects: Ranibizumab*/Ranibizumab*/Ranibizumab*/administration & dosage ; Ranibizumab*/Ranibizumab*/Ranibizumab*/adverse effects ; Retinopathy of Prematurity*/Retinopathy of Prematurity*/Retinopathy of Prematurity*/drug therapy

  • Source: Clinical therapeutics [Clin Ther] 2024 Oct; Vol. 46 (10), pp. 773-777. Date of Electronic Publication: 2024 Oct 05.Publisher: Excerpta Medica Country of Publication: United States NLM ID: 7706726 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
  • 1-10 of  498 results for ""Receptors, Vascular Endothelial Growth Factor""